Introduction
Neuropathic effects of folate deficiency have been widely reported. '-4 In some studies improvement in the neuropathy has coincided with folate administration and relapse has followed cessation of treatment indicating probable cause and effect. Despite this, folate deficiency is not universally accepted as a cause of neuropathy.5 6 Our purpose is to illustrate the neuropathic consequences of folate deficiency by describing a group of 10 patients with a characteristic neuropathy, clinically manifesting as loss of tendon reflexes (knee and ankle), impaired or absent vibration sense, and bilateral extensor plantar responses indicating posterolateral involvement of the spinal cord. The patients were severely deficient in folate.
Patients and methods
Neuropathic findings (absent knee and ankle jerks, loss of vibration sense, and extensor plantar responses) were first noted in an 83-yearold man (case 1) referred from local authority care with a diagnosis of senile dementia because of increasing confusion and difficulty in walking. He had become doubly incontinent. In addition to the neurological findings he had extensive involvement of the left tibia with Paget's disease. Haemoglobin was 10 6 g/dl and mean cell volume 117 fl (117 siM3). Serum B12 levels were normal (340 ng/l), but serum folate concentrations were low (1 sjg/l). Specific treatment with folic acid resulted in unexpected and dramatic resolution of the psychosis and incontinence, and progressive, and ultimately complete, ambulation was achieved. Further neurological examination showed that there was loss of vibration sense in the legs, but pain and tem-perature appreciation was retained. The clinical disorder was therefore indistinguishable from subacute combined degeneration of the spinal cord but was folate-dependent.
The demonstration of a specific neurological lesion in folatedepleted subjects that was reversed by folate treatment would provide conclusive evidence for the neuropathic consequences of folate deficiency. To this end, nine other patients (seven men, two women) with similar neurological abnormalities were identified; they were either already in continuing care or had been referred to a geriatric assessment unit. The clinical details, referral diagnosis, mental state, mobility, and the nature of intercurrent disease in these patients are shown in table I. Blood was withdrawn for standard haematological and biochemical measurements. On the second aliquot the serum folate and vitamin BI 2 levels were measured microbiologically by the Lactobacillus casei and Lactobacillus leishmanii assays respectively. Serum samples were assayed in duplicate. Equivocal values were repeated. The coefficient of variation of replicate measurements for these assays was similar (± 70').
Treatment-Since the patients' serum B12 levels were normal, a trial of oral folic acid (10 mg three times a day) could be carried out. Drug treatment was otherwise rigidly controlled. Two patients (cases 2 and 3) initially received several doses of chlorpromazine. Except in one patient (case 2) formal rehabilitation was not attempted, nor was it required subsequently. Psychiatric intervention was not required. Since all patients were severely disabled and spontaneous improvement was improbable, any response to folic acid would be apparent clinically and could be confidently ascribed to it. Acceptable objective criteria of response would be the restoration of tendon reflexes, the recovery of posterior column sensation, and regression of the extensor plantar Table III shows the response of these neuropathic patients to specific folate treatment. The neuropathy was completely reversed in three patients (cases 2, 7, and 8). In two others (cases 5 and 6) the only residual abnormality was incomplete recovery of vibration sense in the legs. In three others (cases 4, 9, and 10) significant improvement occurred. Two patients (cases 1 and 3) showed no improvement in the reflex and sensory abnormalities, even after 15 months' treatment in case 1. All patients experienced an improvement in mood, and in two patients (cases 2 and 3) psychosis dramatically resolved. The improvement in psyche was discernable within two weeks of starting treatment and preceded the improvement in reflex abnormalities by many weeks, and even months.
Discussion
Unequivocal recognition of the neuropathic role of folate deficiency is essential if the serious consequences of misdiagnos- Haemoglobin (g dl) 11-6 10-2 10-7 9-8 12-2 4-2 14-9 14-8 11-0 12-7
The clinical management of patients suffering from chronic neurological disease is notoriously difficult and tends to induce an attitude of therapeutic nihilism in medical and nursing staff alike. When such a condition is diagnosed the implicit assumption of inexorable progression of the lesion is accepted, hence the failure to review the patients in this series despite the eminently treatable nature of their disorder.
A particular difficulty with the therapeutic use of folic acid is that it can precipitate subacute combined degeneration of the cord in subjects with occult or undiagnosed vitamin BI, deficiency. This is not a reason for withholding folic acid in patients with obscure neurological disease, but rather underlines the need for precise diagnosis. In practice this fear of folate's toxicity is deeply entrenched in the clinical conscience and has proved a powerful disincentive to its prescription. This is all the more unfortunate since available tests permit precise diagnosis of disorders of vitamin B,, metabolism. In difficult cases it would be proper to give both to affected patients. Finally, since it takes several months for folate-induced subacute combined degeneration of the cord to develop,'4 a short-term trial (up to four weeks) of folic acid may be conducted in doubtful cases if the techniques, some of which may be esoteric, for distinguishing between the two deficiencies are not readily available to the clinician.
The diagnosis of folate deficiency poses several problems. There are no tests comparable to the Dicopac test in disorders of B,,, nor are there parallel markers of folate dysfunction such as antibody studies etc. At present diagnosis depends on showing low folate concentrations in serum or in the red cell. The red cell concentration would be regarded by some workers as a better index of tissue folate deficiency than the serum level. Unfortunately red cell folate values are reduced in some patients with vitamin B,, deficiency and cannot be confidently used to discriminate between the two possibilities'5-a critical consideration in this particular study. It must be accepted that a low serum folate concentration does not necessarily indicate whole body folate deficiency, since the plasma folate compartment is labile and has a rapid turnover. In chronic or long-standing folate deficiency, however, the serum folate concentration represents a true equilibrium state, and low values indicate folate deficiency. The patients in this study were all considered to be suffering from long-standing dietary folate deficiency. The reasons for this have to be carefully elucidated but were not the main purpose of this study.
When the complex interactions between chronic folate deficiency, haemopoiesis, and neurologic function are considered several points emerge. Table II shows that there may be complete dissociation between the haematological and neurological effects and indicates a greater vulnerability of the nervous system to long-standing folate deficiency. The important corollary to this is that a normal haemoglobin level does not exclude the diagnosis of a severe folate-dependent neuropathy. Macrocytosis is a sensitive indicator of occult folate deficiency (table II) , but this effect is masked by concurrent iron deficiency,16 making the diagnosis even more difficult. This problem is illustrated by one of our patients (case 2), who presented with iron deficiency anaemia (nutritional). When this was corrected obvious macrocytosis of the red cells developed. It is interesting, and perhaps clinically significant, that the neurological lesion (spastic paraparesis) progressed rapidly over this same period.
Introduction
The observation that deep venous thrombosis (DVT) may occur in the paralysed leg of patients after cerebrovascular accidents, or strokes, is not new. In 1810 Ferriarl described the clinical signs of DVT in a patient whose leg had been "previously affected by a paralytic stroke" and the necrospy appearance of a thrombus in the deep veins of a paralysed leg was clearly described by Lobstein in 1833.2 Despite these early observations
